Healius | HLS - Pendapatan Penjualan

Keuangan

AUD

AUD 3.07B

AUD 60.1M

Biaya Penjualan

AUD 218.7M

AUD 1.04B

Kewajiban Lancar

AUD 804.2M

AUD 1.4B

Dividen - Hasil

7.19

AUD 23.7M

AUD 74.9M

8K

Eps Laba Per Saham

AUD -0.04

Modal Dan Cadangan

AUD 1.03B

Laba Kotor Pada Penjualan

AUD 554.4M

Beban Bunga Utang

AUD 32.8M

AUD 1.22B

Kapitalisasi Pasar

AUD 290.44M

Batas Pemasukan

AUD -12.8M

Biaya Operasional

AUD 684.9M

Laba Operasional

AUD -22.6M

Modal Saham Biasa

AUD 2.6B

Pe Harga Untuk Laba

57.43

Laba Sebelum Pajak

AUD -19.2M

Pendapatan Penjualan

AUD 688.1M

Beban Penjualan Dan Administrasi

AUD 393.4M

AUD 31.9M

Kreditur Perdagangan

AUD 133.9M

Debitur Perdagangan

AUD 144.6M

	Penjualan	Perubahan		Tanggal
Alcidion	AUD 25.47M		2.32M	2025-12
Ansell	USD 1.03B		192.2M	2025-12
Cochlear	AUD 1.18B		590.35M	2025-12
CSL	USD 8.33B		4.79B	2025-12
Fisher Paykel Healthcare	NZD 1.24B		137.8M	2026-06
Integral Diagnostics	AUD 238.44M		7.19M	2024-06
Mayne Pharma	AUD 212.07M		17.03M	2025-12
Nanosonics	AUD 102.23M		2.8M	2025-12
Polynovo	AUD 70.33M		35.75M	2025-12
Ramsay Health Care	AUD 9.34B		82.2M	2025-12
ResMed	USD 1.43B		8.6M	2026-03
Sigma Healthcare	AUD 1.68B		188.65M	2024-12
Sonic Healthcare	AUD 5.45B		470M	2025-12